Zhejiang Kanglaite Pharmaceutical Co.Ltd   Report issue

For profit Phase 2 Phase 4
Founded: Hangzhou China (1995)
Status: No NME R&D (1995)

Organization Overview

First Clinical Trial
2001
NCT00031031
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

KangLaiTe USA

Active Ingredients

Drugs in Phase 4 Trials (1)

kanglaite (5 trials)

Drugs in Phase 2 Trials (1)

gemcitabine (gemzar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cachexia (Phase 4)

Pancreatic Neoplasms (Phase 2)

Prostatic Neoplasms (Phase 2)

Wasting Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 2